...

Samoa’s Procurement Pattern for Oncology APIs: What Exporters Must Know

Introduction

Samoa is facing a rising cancer burden, with more patients needing treatment each year.

The country depends a lot on imported oncology APIs because local production is low.

According to the WHO, Samoa imports over 95% of its medicines.

Samoa’s rising demand has created a small but important micro-market.

Indian exporters of APIs are finding reliable, specialized markets there.

Overview of Cancer Burden in Samoa

Cancer cases are rising in Samoa and are becoming a serious public health concern.

Below, we explain key cancer numbers, major cancer types, and treatment challenges.

overview of cancer burden in samoa

Key Cancer Statistics

Cancer is now the second leading cause of death in Samoa. Cases have risen in recent years.

This trend affects both men and women, especially older adults.

  • Annual cancer incidence is around 250-300 new cases each year, based on Pacific Community (SPC) data.

  • The cancers with the highest mortality rates are breast, cervical, prostate, and liver cancers.

  • Cancer rates rose from 28.5 per 100,000 in 2007 to about 65.2 per 100,000 by 2016.

  • Samoa has a few advanced oncology treatment facilities. This raises the need for first-line and supportive cancer therapies.

Government Recognition of Cancer as a Priority

The government of Samoa now treats cancer as a major national health priority.

Here are the national strategies, medicine policies, and global partnerships that support cancer care.

NCD Strategy

Samoa’s Non-Communicable Diseases (NCD) Strategy includes cancer.

It groups cancer with diabetes and heart disease. The 2024-2029 action plan focuses on four key areas.

It aims to prevent issues, promote early screening, ensure access to treatment, and raise community awareness.

Essential Medicines

Cancer treatment drugs are on Samoa’s Essential Medicines List (EML).

This follows World Health Organization guidance. It helps people get vital, life-saving cancer medicines.

Global Partnerships

Samoa works with the World Health Organization.

It also teams up with the United Nations Development Programme and the Pacific Community.

They work on better cancer control, health systems, training, and teamwork in the area.

How Samoa Procures Oncology APIs & Finished Formulations

Samoa follows a structured system to buy cancer medicines and raw materials safely.

Below are the centralized processes, budget system, and tender method used.

how samoa procures oncology apis and finished formulations

Centralized Procurement System

Samoa uses a centralized system to buy oncology APIs and finished medicines.

The system ensures quality control. It keeps costs low and promotes fair competition.

This is done using clear international tender processes.

  • The Ministry of Health (MOH) manages all drug purchases and policy decisions.

  • The National Health Service (NHS) takes care of medicines in hospitals. It manages storage, distribution, and supply.

  • The annual budget for pharmaceutical procurement is about USD 8 to 12 million.

  • Procurement takes place through open international tendering. This process ensures transparency.

Tender-Based Requirements

Samoa has strict tender rules. These rules help ensure that cancer medicines are safe, effective, and affordable.

They make sure suppliers meet high international standards.

Here are the key requirements that suppliers need to follow.

  • WHO-GMP or a similar certification is required for all pharmaceutical suppliers.

  • For stability data, it needs to meet the standards for tropical climates, also known as Zone IVb conditions.

  • Generic cancer medicines need to prove they are equivalent to the originals.

  • Preference is given to cost-efficient, high-quality generic suppliers. 

Emergency/Spot Procurement

In Samoa, emergency or spot procurement is used to deal with stock-outs or urgent shortages of oncology drugs.

This system speeds up buying life-saving medicines. It helps when regular tenders are slow.

The rules for documentation can be pretty flexible in some cases.

However, when it comes to approvals, quality checks, and meeting deadlines, things need to move quickly to ensure that patient care is protected.

Oncology APIs & Key Molecules in High Demand

The demand for cancer treatment is rising in many Pacific countries, such as Samoa.

As the number of patients needing therapy grows, so does the need for key ingredients used in cancer medicines.

Below are the most commonly requested cancer treatment molecules in the region.

oncology apis and key molecules in high demand

Most Requested APIs

Several traditional APIs for chemotherapy and hormone therapy continue to be in high demand.

These medicines are used as first-line treatments.

Below are the key molecules commonly requested in the Pacific region.

  • Cyclophosphamide  

  • Doxorubicin

  • Cisplatin

  • Paclitaxel

  • 5-Fluorouracil (5-FU)

  • Capecitabine

  • Letrozole / Anastrozole

  • Tamoxifen

Biologics & Newer Therapies (Emerging Demand)

Demand for advanced cancer medicines is slowly increasing in Pacific markets, including Samoa.

These newer therapies provide targeted treatment. They also lead to better outcomes for some patients.

Here are the main biologics and new immunotherapy drugs that are getting noticed.

Trastuzumab

This is used for HER2-positive breast and gastric cancers.

Biosimilars help make treatment more affordable and accessible.

Rituximab

Using biosimilars can be a big help in treating certain blood cancers and autoimmune diseases.

They also lower the overall cost of treatment.

Pembrolizumab

This is a high-end treatment that involves using the body’s immune system to fight disease.

It’s a rare and expensive medicine. It’s often imported from abroad for special cases where it’s the best choice.

Supportive-Care Products Also Imported

Samoa imports medicines to help manage side effects. These medicines make patients feel better.

They help during treatments like chemotherapy. Here are key supportive care products used in cancer care:

Antiemetics (Ondansetron)

It stops and manages queasiness and vomiting that can happen during chemo treatments.

Filgrastim

This helps the body make more white blood cells after going through chemo.

Dexamethasone

It helps with inflammation and makes severe nausea from treatment more manageable.

Samoa’s Supplier Profile: Who They Import From

Samoa depends a lot on importing medicines and ingredients for cancer treatment.

The main countries that supply oncology drugs and APIs are:

samoas supplier profile who they import from

Dominant Supplier Countries

Samoa relies on trusted partners for its cancer medicines.

These partners are mostly from other countries.

These countries offer final products, generic cancer drugs, and basic active ingredients. The leading supplier nations are:

India (Largest Generic Supplier)

India is a leader in oncology generics. It allows for affordable chemotherapy and hormone therapies.

These medicines are widely used in public hospitals. There, the demand for essential cancer treatments is high.

Australia & New Zealand

Australia and New Zealand are helping Samoa.

They’re sending crucial medical supplies, including medicines and gear that need careful monitoring.

They help keep quality standards high and ensure that supply chains are reliable.

China (APIs & Commodities)

China supplies the basic ingredients and raw materials for medicines, as well as some common drugs.

They support local imports and meet the overall needs for buying pharmaceuticals.

Why Indian API Manufacturers Dominate

India has emerged as a top global source for oncology APIs.

Many small countries and island nations count on Indian API manufacturers.

They trust them for their reliability and good value.

Here are the key reasons why Indian API companies lead:

Cost Advantage

Indian oncology APIs are usually 40-60% cheaper than those from Australia and New Zealand.

Companies can keep prices low by producing on a large scale and managing costs well.

This way, they maintain quality while offering better deals.

Oncology Expertise

Indian manufacturers excel in oncology and HPAPI production.

They make complex chemotherapy drugs and hormone therapies in large amounts.

This helps meet the rising global demand for cancer treatment.

Global Certifications

Many Indian facilities have WHO-GMP and other global certifications.

These approvals matter a lot in government tender evaluations.

They can greatly enhance a company’s credibility and increase its chances of being chosen.

Documentation Strength

Indian suppliers give all the required regulatory documents.

They also provide stability data and technical files.

This excellent documentation support is very helpful for small island nations.

They often lack resources for regulation.

Documentation & Regulatory Requirements for Exporters

documentation and regulatory requirements for exporters

Exporting oncology medicines requires strict regulatory compliance and proper documentation.

Governments check quality, safety, and manufacturing standards before approving imports.

Below, we explain the key documents exporters must submit for approval.

Mandatory Documents

A supplier looking to export oncology APIs and finished medicines to Samoa needs to have its regulatory documents ready.

These papers show that the product is high-quality, safe, and stable in tropical conditions.

Below are the essential mandatory documents.

  • WHO-GMP certificate

  • CPP (Certificate of Pharmaceutical Product)

  • DMF (Drug Master File)

  • Stability data for Zone IVb

  • Batch COA + MSDS

  • BE studies (required when registering a generic finished dosage)

Samoa’s Regulatory Authorities

Samoa has its own set of rules and regulators in place to check if medicines are safe and follow the law.

They check that all imported cancer medicines meet quality and safety standards.

Here are the main groups that oversee regulation and clinical care.

Ministry of Health – Samoa

The Ministry of Health is the main regulatory authority.

It handles registering medicines, getting import permits, and doing quality checks and inspections.

It also makes sure everything complies with national pharmaceutical laws and safety standards.

National Health Service (NHS)

The National Health Service oversees public healthcare in the country.

They are in charge of ensuring hospitals get the medicines they require.

They purchase, store, and distribute these medicines.

They also follow the official list of essential medicines and treatment guidelines for the country.

Pharmacy Council of Samoa

The Pharmacy Council checks on pharmacists and how pharmacies run.

It sets standards for professionals. It lists who can practice and ensures safe medicine use in public and private healthcare.

Registration Timeline

Registering cancer medicines in Samoa is a simple process.

The authorities review the safety, quality, and supporting documents before giving the green light for import and use.

Below are the usual approval timelines and fast-track options.

Average approval time: 3-6 months

Fast-track approvals are possible for:

  • Shortage medicines

  • Essential oncology drugs

Procurement Cycle & Buying Behavior

The procurement cycle follows a yearly plan based on budgets.

Below, we explain how the annual calendar shapes tenders, emergency buying, and budget resets.

procurement cycle and buying behavior

Annual Procurement Calendar

Most public and large organizations plan their buying based on the fiscal year.

Here’s how big tenders take place, how emergency buying works, and how yearly budget resets impact decisions.

  • Large Tenders (Q2-Q3): Major tenders released between July and December.

  • Emergency Procurement (Year-Round): Quick buys for unexpected needs at any time.

  • Budget Allocation (Fiscal Reset – July): New budgets get approved, and spending plans restart each year.

Purchase Quantities

Purchase quantities in oncology are planned carefully.

Here are the order patterns, batch systems, emergency needs, and small purchases supported by NGOs.

Small but Recurring Orders

These are medicines that are ordered several times a year in small amounts.

They support regular treatment needs and avoid stock gaps.

Oncology Procurement Divided Into

Quarterly Batches

Large planned orders are placed every three months.

This helps to gain better prices and manage storage safely.

Emergency Shipments

Small urgent orders during stock-outs or sudden demand rise.

Ensures patients continue treatment without harmful delays.

NGO-Funded Procurement (Small Quantities)

Small orders are supported by donor or charity programs.

They are often used for rare cancers or special patient groups.

Payment Terms

Payment terms are set to reduce risk and ensure timely supply.

Below are the common payment methods used by government buyers and NGOs.

Letter of Credit

Most purchases are made using a Letter of Credit (LC).

The bank guarantees payment to the supplier after the required documents are submitted and verified.

Government Credit

Some suppliers allow 30–60 days of payment credit. This is often supported by a government guarantee.

This gives suppliers safety and helps buyers manage short-term funds.

Direct Transfers

NGOs often use direct bank transfers for payments. Funds are sent to suppliers electronically.

This speeds up the process and simplifies smaller, donor-funded purchases.

Logistics & Shipping Considerations for Oncology APIs

Safe delivery of oncology APIs needs careful planning and control.

Below are the temperature care, safe handling, compliance, and secure transport that are important for medicines.

logistics ans shipping considerations for oncology apis

Key Ports

Apia Port is the main entry point for oncology APIs into Samoa.

The port must handle refrigerated containers. It should provide safe storage.

Quick customs clearance is also needed.

Strong cold chain control, secure handling, and the right documents help prevent damage, delays, and lost products.

Shipping Requirements

Shipping oncology APIs needs strict rules to keep products safe and effective.

Required shipping requirements are:

  • Temperature-sensitive oncology APIs require a cold chain.

  • Dangerous Goods Certificate (DG) for cytotoxic APIs.

  • Smaller consignments are usually shipped via air cargo.

  • Ocean freight is used for large-volume basic APIs.

Common Challenges

Shipping oncology APIs to small island nations comes with many risks.

Key problems include:

Cold-Chain Limits

Many small islands have limited refrigerated storage and few reefer containers.

They also face an unstable power supply.

This makes it tough to keep oncology APIs at safe temperatures during storage and transport.

Customs Delays

Slow document checks, few staff, and weak coordination between agencies can delay cargo release.

Even short delays may reduce product shelf life and increase storage and penalty charges.

High Freight Costs

Small shipments and long distances raise shipping costs.

Limited routes and fuel reliance make transport costly.

This is especially true for urgent and temperature-sensitive oncology APIs.

Market Opportunities for API Exporters

API exporters can find strong growth in oncology markets. New opportunities are emerging.

This is due to a growing need for treatment, changing health trends, and support from funders.

market opportunities for api exporters

Growing Demand for Oncology Treatments

Demand for cancer treatment is rising across many countries.

Demand for oncology treatments is increasing due to:

  • The aging population and high NCD rates increase cancer cases.

  • Hospitals are moving to newer and better chemotherapy methods.

  • Governments are boosting funding. They are supporting cancer care and treatment programs.

Gaps That Indian Exporters Can Fill

Indian exporters excel in pharma production due to their strong skills and cost benefits.

They meet unmet needs in oncology APIs by focusing on:

Affordable Generics

Indian companies can offer low-cost generic oncology APIs. Their large-scale production keeps costs low.

This helps hospitals and governments cut treatment costs. They can do this without lowering quality.

HPAPI Capability

Indian manufacturers are investing in safe facilities. These facilities focus on high-potency APIs.

These advanced plants manage powerful oncology molecules.

They follow strict safety rules and have trained staff.

Regulatory Support

Exporters provide key documents such as DMFs and compliance certificates.

This speeds up approvals, eases customs clearance, and builds trust with global buyers.

Flexible Batches

Many buyers need small or mid-size quantities. Indian firms provide flexible production runs.

This makes it easier for them to supply smaller markets and special treatment programs.

Stable Formulations

Indian companies develop temperature-stable oncology APIs.

These products are easier to move, especially to warm areas. They also lower risks during long-distance shipping.

High-Opportunity Segments

The oncology API market is growing fast across the world. Here are the main product segments.

They have high demand, steady growth, and strong export potential for manufacturers.

Solid-Tumor APIs

Chemotherapy drugs for solid tumors are in high demand.

This includes drugs for breast, lung, and colon cancers.

These treatments are common, so their APIs are crucial for hospitals and cancer care centers.

Hormonal Therapies

Hormonal oncology APIs are typically used to treat breast and prostate cancers.

They help slow down cancer growth and are often taken over a long period, which leads to ongoing demand.

Supportive Injectables

Chemotherapy patients often need supportive care injectables.

These include medicines for nausea, infection control, and low blood counts.

This creates a similar demand for these drugs alongside cancer treatment.

Ready Documentation

Buyers prefer APIs with complete DMF and CTD files. Ready documentation speeds up approval.

It makes registration simpler and helps entry into regulated and semi-regulated markets easier.

Strategic Recommendations for Exporters

Exporters must plan carefully to succeed in small and tropical markets.

Below are the actions that improve compliance, speed, flexibility, and long-term partnerships with health authorities and global agencies.

strategic recommendations for exporters

Zone IVb Data

Maintain stability studies for hot and humid climates under Zone IVb conditions.

This confirms product quality over time. It also speeds up approvals in tropical countries that have strict rules.

Small MOQs

Offer low minimum order quantities for micro-markets. Smaller batches lower costs for buyers.

They also help serve island nations and small countries better.

Emergency Response

Build systems for quick supply during urgent tenders or stock-outs.

Keep buffer inventory and clear logistics plans. This helps to respond quickly to urgent procurement needs.

DG Packaging

Use certified packaging for dangerous goods. This is important for cytotoxic and hazardous oncology APIs.

To lower risks when transporting goods, correct labeling is key.

This helps avoid rejected shipments. Safety documents are also needed, and handlers must receive proper training.

Regulatory Support

Share complete dossiers, with CTD and DMF files, to help speed up product registration.

Quick responses to official requests speed up the approval process.

MOH & NGOs

Partner with Ministries of Health and agencies like the World Health Organization, United Nations Development Programme, and Pacific Community.

This will help to get long-term supply programs. It will also build a trusted supplier status.

About the Author

Nilesh Mendpara MD of ACTIZA PHARMA Profile Image
Nilesh Mendpara

Nilesh Mendpara is the Managing Director of Actiza Pharmaceutical PVT. LTD., based in Surat, Gujarat, India. With over 10 years of experience in the pharmaceutical industry, Nilesh is passionate about spreading pharmaceutical knowledge and staying ahead of industry trends. He holds a Master of Pharmacy (Distinction) and a Bachelor's in Pharmacy from Rajiv Gandhi University of Health Sciences. Under his leadership, Actiza Pharmaceutical aims to be the most trusted partner for pharmaceutical exports worldwide, ensuring the highest standards of quality and safety. Connect with Nilesh to explore opportunities in advancing global healthcare.

[Read more]
Request A Call Back

We are a 100% export-oriented company and do not engage in domestic sales within India.

Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.